SKI Market

A+| A| A-|

Indian Indices

Sensex

77,054.18 -101.44
( -0.13%)

Global Indices

Nasdaq

51,515.27 -505.40
(-0.97%)

Dow Jones

7,441.22 -91.13
(-1.21%)

Hang Seng

69,975.80 571.30
(0.82%)

Nikkei 225

10,505.62 11.41
(0.11%)

Forex

USD-INR

94.55 -0.09
(-0.09%)

EUR-INR

109.66 -0.13
(-0.12%)

GBP-INR

126.84 -0.25
(-0.20%)

JPY-INR

0.59 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Lupin Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500257

INE326A01037

659.0470742

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

LUPIN

17.18

103645.47

EPS(TTM)

Face Value()

Div & Yield %

131.91

0.79

Date	Headline
08-Jun-2026	Lupin partners with Spain’s ERN for launch of asthma, COPD inhaler Luforbec
08-Jun-2026	Lupin launches Luforbec® inhaler in Spain
05-Jun-2026	Lupin gains after receiving USFDA nod for Ranluspec
03-Jun-2026	Lupin and alliance partner Natco receive USFDA approval for Eribulin Mesylate Injection
28-May-2026	Lupin receives Establishment Inspection Report for its Ankleshwar unit
19-May-2026	Lupin features in Dow Jones Best-in-Class (DJBIC) indices
08-May-2026	Board of Lupin recommends final dividend
08-May-2026	Lupin consolidated net profit rises 89.04% in the March 2026 quarter
08-May-2026	Lupin Q4 PAT jumps 87.72%; EBITDA margin expands 1,070 bps
05-May-2026	Lupin wins USFDA approval for Glycerol Phenylbutyrate oral liquid

<< < 1 2 3 ... > >>

77,054.18 -101.44 ( -0.13%)

51,515.27 -505.40 (-0.97%)

7,441.22 -91.13 (-1.21%)

69,975.80 571.30 (0.82%)

10,505.62 11.41 (0.11%)

94.55 -0.09 (-0.09%)

109.66 -0.13 (-0.12%)

126.84 -0.25 (-0.20%)

0.59 0.00 (-0.20%)